TransCode Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNAZ and other ETFs, options, and stocks.

About RNAZ

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. Its lead product candidate is TTX-MC138, an antisense inhibitor of an oncogenic microRNA. 

CEO
Philippe P. Calais, PhD
CEOPhilippe P. Calais, PhD
Employees
12
Employees12
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2016
Founded2016
Employees
12
Employees12

RNAZ Key Statistics

Market cap
3.06M
Market cap3.06M
Price-Earnings ratio
-0.07
Price-Earnings ratio-0.07
Dividend yield
Dividend yield
Average volume
20.64K
Average volume20.64K
High today
$3.70
High today$3.70
Low today
$3.21
Low today$3.21
Open price
$3.50
Open price$3.50
Volume
41.01K
Volume41.01K
52 Week high
$20.99
52 Week high$20.99
52 Week low
$3.21
52 Week low$3.21

Stock Snapshot

The current TransCode Therapeutics(RNAZ) stock price is $3.42, with a market capitalization of 3.06M. The stock trades at a price-to-earnings (P/E) ratio of -0.07.

As of 2026-08-16, TransCode Therapeutics(RNAZ) stock has fluctuated between $3.21 and $3.70. The current price stands at $3.42, placing the stock +6.5% above today's low and -7.6% off the high.

TransCode Therapeutics(RNAZ) shares are trading with a volume of 41.01K, against a daily average of 20.64K.

In the last year, TransCode Therapeutics(RNAZ) shares hit a 52-week high of $20.99 and a 52-week low of $3.21.

In the last year, TransCode Therapeutics(RNAZ) shares hit a 52-week high of $20.99 and a 52-week low of $3.21.

People also own

Based on the portfolios of people who own RNAZ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.